The cost of the financing is of grearest concern

The cost of the financing is of grearest concern to me. Given that rmhb has lost money in every quarter since the old THCZ drinks were first launched in 2015, financing will be a risky undertaking by any investment bank especially considering the competitiveness of the beverage industry. I am convinced the financing will be toxic to shareholders, the big question is "How toxic?"

I don't believe there is any way the simple announcement of a funding package will be a sufficient catalyst for a bounce above .045>.05 at best, and that's a stretch. An increase in the authorized shares (currently reported as 800 million on OTCMarkets.com of which nearly all are issued) is probably going to be concurrent with the funding announcement. That represents the only capital/collateral they have to entice a lender. That, or they subordinate a portion of future sales revenues to the lender based on the strength of the marketing acumen of Gerry and Kevin, assuming they stick around.

Then, and only then, do we get to the 10K annual report at the end of the month. The effect of the report, which will be dismal, at best, is much dependent on the funding package and cost thereof.